Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classifica tra le azioni #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prezzo delle azioni
$481.73
Capitalizzazione di mercato
$377.65B
Variazione (1 giorno)
-0.96%
Variazione (1 anno)
50.07%
Paese
CH
Scambia Roche Holding AG (RO)

Categoria

EPS per Roche Holding AG (RO)
EPS al December 2025 TTM: $20.39
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Roche Holding AG, l’EPS attuale della società (TTM) è $20.39. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Roche Holding AG da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$29.85 46.40%
US
$8.65 -57.58%
US
$3.55 -82.59%
US
$1.26 -93.82%
US
$7.19 -64.74%
CH